Intravenous high dose vitamin C and selected antiviral drugs in hospitalized COVID-19 patients: a descriptive cohort study

Introduction: There is lack of universal agreement on the management of COVID-19. Intravenous high dose vitamin C (HDVC), remdesivir (RDV), and favipiravir (FPV) have been suggested as part of the treatment regimens and only RDV is approved by the Food and Drug Administration (FDA) so far. There is...

Full description

Bibliographic Details
Published in:Journal of Infection in Developing Countries
Main Authors: Mohamad Fleifel, Jonathan Mina, Tony Haykal, Rana Asmar, Ghida El Hout, Ranime Harb, Hani Dimassi, Jacques Mokhbat, Anna Farra, Rola Husni-Samaha
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2022-10-01
Subjects:
COVID-19
Remdesivir
Favipiravir
Vitamin C
retrospective study
Lebanon
Online Access:https://jidc.org/index.php/journal/article/view/16884

Internet

https://jidc.org/index.php/journal/article/view/16884

Similar Items